These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 1434754)
1. Antiprogestin drugs: ethical, legal and medical issues. Cook RJ; Grimes DA Law Med Health Care; 1992; 20(3):149-53. PubMed ID: 1434754 [TBL] [Abstract][Full Text] [Related]
2. Antiprogestin drugs: ethical issues. Macklin R Law Med Health Care; 1992; 20(3):215-9. PubMed ID: 1434763 [TBL] [Abstract][Full Text] [Related]
3. RU 486 in France and England: corporate ethics and compulsory licensing. Boland R Law Med Health Care; 1992; 20(3):226-34. PubMed ID: 1434766 [TBL] [Abstract][Full Text] [Related]
4. RU-486: legal and policy issues confronting the Food and Drug Administration. Muhl C J Leg Med; 1993 Jun; 14(2):319-47. PubMed ID: 8340714 [TBL] [Abstract][Full Text] [Related]
5. Updating RU 486 development. Baulieu EE Law Med Health Care; 1992; 20(3):154-6. PubMed ID: 1434755 [TBL] [Abstract][Full Text] [Related]
6. Recent developments in abortion law in industrialized countries. Boland R Law Med Health Care; 1990; 18(4):404-18. PubMed ID: 2089193 [TBL] [Abstract][Full Text] [Related]
7. Benten v. Kessler: the RU 486 import case. Pine RN Law Med Health Care; 1992; 20(3):238-42. PubMed ID: 1434768 [TBL] [Abstract][Full Text] [Related]
8. RU 486 approved in Britain; U.S. research still limited. Contracept Technol Update; 1991 Sep; 12(9):144-7. PubMed ID: 12317312 [TBL] [Abstract][Full Text] [Related]
9. Antiprogestin drugs: research and clinical use in Sweden. Bygdeman M; Swahn ML Law Med Health Care; 1992; 20(3):157-60. PubMed ID: 1434756 [TBL] [Abstract][Full Text] [Related]
10. Boycott threat forces French company to abandon RU486. Dorozynski A BMJ; 1997 Apr; 314(7088):1150. PubMed ID: 9146386 [TBL] [Abstract][Full Text] [Related]
11. Studying the acceptability and feasibility of medical abortion. Winikoff B; Coyaji K; Cabezas E; Coyaji B; Krishna U; de la Concepcion O; Eschen A; Sivin I; Brady M Law Med Health Care; 1992; 20(3):195-8. PubMed ID: 1434760 [TBL] [Abstract][Full Text] [Related]
12. Roussel-Uclaf to transfer RU 486 rights. Reprod Freedom News; 1997 Apr; 6(7):8. PubMed ID: 12292550 [TBL] [Abstract][Full Text] [Related]
13. The RU 486 story: the French experience. Sharts-Engel NC MCN Am J Matern Child Nurs; 1992; 17(1):56. PubMed ID: 1738308 [TBL] [Abstract][Full Text] [Related]
14. RU-486 and the politics of reproduction. Rosenfield A Female Patient; 1989 Mar; 14(3):69, 73-4. PubMed ID: 12342816 [TBL] [Abstract][Full Text] [Related]
15. Contemporary transatlantic developments concerning compelled medical treatment of pregnant women. Rossiter GP Aust N Z J Obstet Gynaecol; 1995 May; 35(2):132-8. PubMed ID: 7677674 [TBL] [Abstract][Full Text] [Related]
16. RU 486: an alternative to surgical abortion. Donaldson K; Briggs J; McMaster D J Obstet Gynecol Neonatal Nurs; 1994 Sep; 23(7):555-9. PubMed ID: 7996306 [TBL] [Abstract][Full Text] [Related]
17. RU486: a compound that gets itself talked about. Baulieu EE Hum Reprod; 1994 Jun; 9 Suppl 1():1-6. PubMed ID: 7962455 [TBL] [Abstract][Full Text] [Related]
18. Great Britain second country to allow use of RU-486. Smith W Plan Parent Eur; 1991 Sep; 20(2):20. PubMed ID: 12284548 [TBL] [Abstract][Full Text] [Related]
19. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment. Henshaw RC; Naji SA; Russell IT; Templeton AA BMJ; 1993 Sep; 307(6906):714-7. PubMed ID: 8401094 [TBL] [Abstract][Full Text] [Related]